BREAKING: ASPIRIN Reduces Covid Ventilation 44%, ICU Admissions 43% and Hospital Deaths 47%

Aspirin lowers risk of COVID: New findings support preliminary Israeli trial

The treatment reduced the risk of reaching mechanical ventilation by 44%. ICU admissions were lower by 43%, and an overall in-hospital mortality saw a 47% decrease.

By JERUSALEM POST STAFF OCTOBER 6, 2021 13:51


Over-the-counter aspirin could protect the lungs of COVID-19 patients and minimize the need for mechanical ventilation, according to new research at the George Washington University.

The team investigated more than 400 COVID patients from hospitals across the United States who take aspirin unrelated to their COVID disease, and found that the treatment reduced the risk of several parameters by almost half: reaching mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%.

“As we learned about the connection between blood clots and COVID-19, we knew that aspirin – used to prevent stroke and heart attack – could be important for COVID-19 patients,” said Dr. Jonathan Chow of the study team. “Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death.”

CONTINUED AT:
[link to www.jpost.com (secure)]

Last Edited by Doc Savage on 10/11/2021 04:14 PM